
Taking a Closer Look At Vanda Pharmaceuticals Inc (VNDA) Following Its Recent Trade
Vanda Pharmaceuticals Inc’s filing revealed that its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $41500.0 on
Vanda Pharmaceuticals Inc’s filing revealed that its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $41500.0 on
Vanda Pharmaceuticals Inc’s recent filing unveils that its Director Mitchell Stephen Ray unloaded Company’s shares for reported $32130.0 on Jun
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Vanda Pharmaceuticals
Vanda Pharmaceuticals Inc’s filing revealed that its Director Mitchell Stephen Ray unloaded Company’s shares for reported $32130.0 on Jun 13
Vanda Pharmaceuticals Inc’s recent filing unveils that its Director Mitchell Stephen Ray unloaded Company’s shares for reported $32130.0 on Jun
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Vanda Pharmaceuticals Inc’s recently made public that its Director Mitchell Stephen Ray unloaded Company’s shares for reported $32130.0 on Jun
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Vanda Pharmaceuticals Inc revealed its Director Mitchell Stephen Ray unloaded Company’s shares for reported $32130.0 on Jun
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or